Mylan Insulin Aspart Study

Clinical trial NCT03760068 · COMPLETED

Trial details

NCT number: NCT03760068
Sponsor: Mylan Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2018-11-07
Primary completion: 2019-12-28
Enrollment: 478

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.